| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Goat |
| Applications | ELISA,WB-Ti |
| Brand: | Abnova |
| Reference: | PAB6875 |
| Product name: | PCK2 polyclonal antibody |
| Product description: | Goat polyclonal antibody raised against synthetic peptide of PCK2. |
| Gene id: | 5106 |
| Gene name: | PCK2 |
| Gene alias: | PEPCK|PEPCK-M|PEPCK2 |
| Gene description: | phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
| Immunogen: | A synthetic peptide corresponding to human PCK2. |
| Immunogen sequence/protein sequence: | KPWKPGDKEPCAH |
| Protein accession: | NP_004554.2 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:8000) Western Blot (0.5-1 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Specificity: | This antibody is expected to recognize isoform 1 (NP_004554) only, no cross-reactivity with PCK1. |
| Reactivity: | Human |
| Application image: | ![]() |
| Application image note: | PCK2 polyclonal antibody (Cat # PAB6875) (0.5 ug/mL) staining of human liver lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. |
| Applications: | ELISA,WB-Ti |
| Shipping condition: | Dry Ice |
| Publications: | Expression of phosphoenolpyruvate carboxykinase gene in human adipose tissue: induction by rosiglitazone and genetic analyses of the adipocyte-specific region of the promoter in type 2 diabetes.Duplus E, Benelli C, Reis AF, Fouque F, Velho G, Forest C. Biochimie. 2003 Dec;85(12):1257-64. |